Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G for Ventyx Biosciences, Inc. Common Stock (VTYX).
- Disclosed ownership: 6%.
- Date of event: 31 Dec 2025.
MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G Report for Ventyx Biosciences, Inc. Common Stock (VTYX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- VTYX
- Shares outstanding
- 71,498,583 shares
- Disclosed Ownership
- 4,289,915 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2026, 16:53:27 UTC
- Date of event
- 31 Dec 2025
- Next filing
- 06 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 6% ownership in Ventyx Biosciences, Inc. Common Stock (VTYX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2026, 16:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 6% | 4,289,915 | 0 | 2,285,401 | Chris O'Hara | Authorized Signatory, Morgan Stanley |